Editor's Audio Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor, the Journal of the American Medical Association, for the April 09, 2014 issue
Muntner and coauthors report on validation of the atherosclerotic CVD pooled cohort risk equations. In an accompanying Editorial, Krumholz provides persective on the new cholesterol and blood pressure guidelines.
Kavousi and coauthors compared population-wide implications of the ACC/AHA, Adult Treatment Panel III, and European Society of Cardiology guidelines for cardiovascular disease (CVD) prevention in 4854 Dutch Rotterdam Study participants. Krumholz comments in an editorial.
J.-K. Lee and coauthors performed a systematic review and meta-analysis to determine the association between survival and first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors vs chemotherapy among patients with advanced non–small cell lung cancer with wild-type EGFR.